|

M032 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • University of Alabama at Birmingham1
  • M.D. Anderson Cancer Center1

Indications

  • Cancer2
  • Gliosarcoma1
  • Anaplastic Astrocytoma1
  • Glioblastoma Multiforme1
  • Glioma1

Birmingham, Alabama1 trial

Study of Pembrolizumab and M032 (NSC 733972)

University of Alabama at Birmingham

Phase 1/2

Houston, Texas1 trial

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

The University of Texas M. D. Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.